Bicara Therapeutics Inc.

BCAX

$9.76−44.16% 1D

$13.7052-week range$30.99

Updated Oct 29, 2026, 05:23 AM UTC. Prices are snapshots and may be delayed.

Open full workspace

Bicara Therapeutics Inc. price chart

−44.47% over 7D

$17.65

$8.93

Oct 27

Oct 29

AI Outlook for Bicara Therapeutics Inc.

Bearish posture

Long-term trend
-54.2% vs 200-day average
Medium-term trend
-52.1% vs 50-day average
Averages
50-day below 200-day

3 more trend and momentum checks
Nearby support and resistance levels
What would strengthen or weaken the picture

See plans to unlock Open BCAX in the workspace

Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out

Bicara Therapeutics Inc. performance

−44.2%

−45.5%

30D

−48.1%

90D

−62.8%

−40.7%

About Bicara Therapeutics Inc.

Bicara Therapeutics Inc. is a biotechnology company based in the United States, listed on NASDAQ since 2024 (ticker BCAX).

Bicara Therapeutics Inc. market data

What is the price of Bicara Therapeutics Inc. today?

Bicara Therapeutics Inc. (BCAX) is at $9.76, −44.16% on the day.

What is the 52-week range of Bicara Therapeutics Inc.?

Over the past year Bicara Therapeutics Inc. has traded between $13.70 and $30.99. It is currently -23% of the way up that range.

Similar stocks

Alphabet Inc. Class A Common Stock

Space Exploration Technologies Corp

$145.23−2.3%